We are live on ! Find out more
BMEZ icon

BlackRock Health Sciences Trust II

99 hedge funds and large institutions have $710M invested in BlackRock Health Sciences Trust II in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 37 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

11% more capital invested

Capital invested by funds: $641M → $710M (+$69.7M)

0.34% less ownership

Funds ownership: 38.81%38.46% (-0.34%)

6% less funds holding

Funds holding: 10599 (-6)

22% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 37

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

Holders
99
Holders Change
-6
Holders Change %
-5.71%
% of All Funds
1.43%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
12
Increased
29
Reduced
37
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Saba Capital Management
New York
$336M +$58.4M +3,705,172 +22%
Morgan Stanley
2
Morgan Stanley
New York
$62.4M -$60.8M -3,857,339 -50%
SIA
3
Sit Investment Associates
Minnesota
$27.3M +$18.6M +1,181,677 +246%
RCM
4
Rivernorth Capital Management
Florida
$25.2M -$6.85M -434,187 -22%
Invesco
5
Invesco
Georgia
$24.5M +$2.27M +143,679 +11%
SC
6
Sessa Capital
New York
$23.9M +$23M +1,457,734 New
Bank of America
7
Bank of America
North Carolina
$23.3M -$1.98M -125,708 -8%
KIM
8
Karpus Investment Management
New York
$22.9M +$2.86M +181,092 +15%
UBS Group
9
UBS Group
Switzerland
$22.3M +$265K +16,804 +1%
1CP
10
1607 Capital Partners
Virginia
$22M -$3.4M -215,566 -14%
AC
11
Almitas Capital
California
$15.3M -$5.71M -362,293 -28%
Lazard Asset Management
12
Lazard Asset Management
New York
$13.1M +$2.47M +156,417 +24%
Wells Fargo
13
Wells Fargo
California
$12.5M -$643K -40,809 -5%
RJA
14
Raymond James & Associates
Florida
$8.36M -$90.9K -5,765 -1%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$5.93M +$57.6K +3,650 +1%
COLIM
16
City of London Investment Management
United Kingdom
$4.96M -$488K -30,917 -9%
Stifel Financial
17
Stifel Financial
Missouri
$4.74M +$348K +22,039 +8%
LCM
18
Landscape Capital Management
New Jersey
$4.4M -$3.76M -238,629 -47%
AA
19
AQR Arbitrage
Connecticut
$4.38M -$3.07M -194,633 -42%
Allspring Global Investments
20
Allspring Global Investments
North Carolina
$3.94M -$536K -34,022 -12%
RJFSA
21
Raymond James Financial Services Advisors
Florida
$3.11M +$544K +34,523 +22%
QC
22
Quantedge Capital
Singapore
$3.02M -$3M -190,561 -51%
LPL Financial
23
LPL Financial
California
$2.94M +$169K +10,708 +6%
OC
24
Oppenheimer & Co
New York
$2.38M +$1.08M +68,569 +89%
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$2.33M +$87.3K +5,537 +4%

BMEZ Hedge Fund Activity: Q1 2024 in Review

99 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q1 2024, worth a combined $710M — up 11% from $641M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of BMEZ and 12 opened new positions — a net loss of 6 holders — while 37 trimmed existing stakes and 29 added.

The largest buyer was Saba Capital Management, adding an estimated $58.4M. The largest seller was Morgan Stanley, cutting an estimated $60.8M.

  • 99 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q1 2024, down from 105 in Q4 2023.
  • Funds reported $710M of BlackRock Health Sciences Trust II stock for Q1 2024, up 11% quarter-over-quarter.
  • 12 funds opened new BlackRock Health Sciences Trust II positions in Q1 2024 and 18 closed out, a net change of -6 holders.
  • The largest BlackRock Health Sciences Trust II buyer in Q1 2024 was Saba Capital Management, an estimated $58.4M added.
  • The largest BlackRock Health Sciences Trust II seller in Q1 2024 was Morgan Stanley, an estimated $60.8M sold.

Based on aggregated 13F filings for Q1 2024.